Feng Han has 30 years of healthcare operational and investment experiences on a global basis in MedTech, pharma/biotech, and healthcare service sectors.  His professional experiences include Partner at Pagoda Capital, an established global technology and healthcare investment firm headquartered in Beijing; Managing Director at Fosun Group based in New York, responsible for overseas healthcare private equity investment for one of the largest asset management firms from China; Director Corporate Business Development at Henry Schein, where he led M&A activities in Asia Pacific on behalf of one of the Fortune 500 MedTech companies in the US.  He previously also had management positions with Sanofi Pasteur and R&D experiences in vaccine industry in China. Mr. Han currently is a member of the Board of Directors of Hamilton Thorne Ltd., a US public MedTech company.

Feng holds an MBA in Finance and Marketing from the Wharton School, University of Pennsylvania; an MS in Microbiology and Molecular Genetics from Michigan State University, and a BS in Microbial Engineering from Shandong University.

Feng resides in Long Island, New York and is an avid skier in winter and an enthusiastic cyclist in summer. He enjoys reading, traveling, and going on long hikes with his wife and three children.